Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Divestments (2023)

Emergent BioSolutions (EBS) posted Divestments of $74.9 million for Q2 2023.

Analysis

Emergent BioSolutions (EBS) Divestments (2023) Analysis & Trends

Emergent BioSolutions has reported Divestments for 1 years, with the latest figure at $74.9 million in Q2 2023.

  • On a quarterly basis, Divestments changed N/A year-over-year to $74.9 million in Q2 2023; TTM through Dec 2024 was $74.9 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $110.2 million, down 59.22% from the prior year.
  • Divestments was $74.9 million for Q2 2023 at Emergent BioSolutions.
  • The five-year high for Divestments was $74.9 million in Q2 2023, with the low at $74.9 million in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn -
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn -
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn -
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 62.00 Mn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 1.88 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 209.00 Mn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn -
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn -
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 74.90 Mn
API Access

Emergent BioSolutions Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=EBS&period=max&api_key=YOUR_API_KEY